Oropharyngeal Cancers Recruiting Phase 1 / 2 Trials for Aldesleukin (DB00041)

Also known as: Oropharyngeal Cancer / Cancer of Oropharnyx

IndicationStatusPhase
DBCOND0042409 (Oropharyngeal Cancers)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02858310E7 TCR T Cells for Human Papillomavirus-Associated CancersTreatment